2-(7-(4-Fluorobenzylidene)-3-(4-fluorophenyl)-3,3a,4,5,6,7-hexahydro-2H-indazol-2-yl)-2-oxoethyl pyrazine-2-carboxylate

Catalog No. :
ACRSUE113
CAS No. :
455300-59-1
Molecular Formula :
C27H22F2N4O3
Molecular Weight :
488.49

IUPAC Name:(Z)-2-(7-(4-fluorobenzylidene)-3-(4-fluorophenyl)-3,3a,4,5,6,7-hexahydro-2H-indazol-2-yl)-2-oxoethyl pyrazine-2-carboxylate

2-(7-(4-Fluorobenzylidene)-3-(4-fluorophenyl)-3,3a,4,5,6,7-hexahydro-2H-indazol-2-yl)-2-oxoethyl pyrazine-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(7-(4-Fluorobenzylidene)-3-(4-fluorophenyl)-3,3a,4,5,6,7-hexahydro-2H-indazol-2-yl)-2-oxoethyl pyrazine-2-carboxylate
IUPAC Name(Z)-2-(7-(4-fluorobenzylidene)-3-(4-fluorophenyl)-3,3a,4,5,6,7-hexahydro-2H-indazol-2-yl)-2-oxoethyl pyrazine-2-carboxylate
Molecular FormulaC27H22F2N4O3
Molecular Weight488.49
SMILESFC(C=C1)=CC=C1/C=C2C3=NN(C(COC(C4=NC=CN=C4)=O)=O)C(C5=CC=C(F)C=C5)C3CCC\2
InChI KeyFPROZYXVPDQQFZ-RGEXLXHISA-N
Synonym2-Pyrazinecarboxylic acid, 2-[3-(4-fluorophenyl)-7-[(4-fluorophenyl)methylene]-3,3a,4,5,6,7-hexahydro-2H-indazol-2-yl]-2-oxoethyl ester
CAS No.455300-59-1
PubChem CID6165130

Synthetic Route by SureRoute

1. ACRSUE113 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACZXFO064 route compound structure diagram
    ACZXFO06498-97-5 In Stock
  4. Then
  5. ACRSUE113 route product structure diagram
    ACRSUE113455300-59-1
Inquiry

2. ACRSUE113 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRSUE113 route product structure diagram
    ACRSUE113455300-59-1
Inquiry

Comments (0)